Cover Image

Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis

Background In order to relieve the financial burden of the patients in China, the Ministry of Health (MoH) conducted the first national price negotiation and successfully negotiated three expensive medicines including 2 targeted anticancer medicines (TAMs), icotinib and gefitinib. However, little e...

Full description

Saved in:

Bibliographic Details
Main Authors:	Cong Huang (Author), Carolina Ung (Author), Haishaerjiang Wushouer (Author), Lin Bai (Author), Xinyi Li (Author), Xiaodong Guan (Author), Luwen Shi (Author)
Format:	Book
Published:	Kerman University of Medical Sciences, 2022-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
by: Cong Huang, et al.
Published: (2022)

Influence of Government Price Regulation on the Price, Volume and Spending of Antibiotics in China: A Controlled Interrupted Time Series Study
by: Haishaerjiang Wushouer, et al.
Published: (2022)

Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017
by: Lin Bai, et al.
Published: (2020)

The Impact of Sanming Healthcare Reform on Antibiotic Appropriate Use in County Hospitals in China
by: Lin Hu, et al.
Published: (2022)

Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, China
by: Tao Huang, et al.
Published: (2022)

Trends in accessibility of negotiated targeted anti-cancer medicines in Nanjing, China: An interrupted time series analysis
by: Yanyan Liu, et al.
Published: (2022)

Medical insurance and healthcare utilization among the middle-aged and elderly in China: evidence from the China health and retirement longitudinal study 2011, 2013 and 2015
by: Yue Zhou, et al.
Published: (2020)

Impact of medical insurance access negotiation on the utilization of innovative anticancer drugs in China: an interrupted time series analysis
by: Cui Li, et al.
Published: (2024)

Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study
by: Hong Zhu, et al.
Published: (2022)

Outpatient Antibiotic Prescribing Patterns and Appropriateness for Children in Primary Healthcare Settings in Beijing City, China, 2017-2019
by: Haishaerjiang Wushouer, et al.
Published: (2021)

Acid Suppression Use Among Infants in One Tertiary Children's Hospital in China, 2015-2018: A Retrospective Observational Study
by: Yue Zhou, et al.
Published: (2021)

New Evidence of the Impact of the National Drug Price Negotiation Policy on the Availability, Utilization, and Cost of Anticancer Medicines in China: An Interrupted Time Series Study
by: Gao X, et al.
Published: (2024)

Trends of Fixed-Dose Combination Antibiotic Consumption in Hospitals in China: Analysis of Data from the Center for Antibacterial Surveillance, 2013-2019
by: Haishaerjiang Wushouer, et al.
Published: (2022)

The Impact of Prescribing Monitoring Policy on Drug Use and Expenditures in China: A Multi-center Interrupted Time Series Study
by: Xiaoyan Nie, et al.
Published: (2023)

Exploring Facilitators and Barriers to Delayed Antibiotic Prescribing in Rural Northwest China: A Qualitative Study Using the Theoretical Domains Framework and Behavior Change Wheel
by: Haishaerjiang Wushouer, et al.
Published: (2023)

Safety of medication use during pregnancy in mainland China: based on a national health insurance database in 2015
by: Jingyuan Zhang, et al.
Published: (2019)

Antibiotic use and irrational antibiotic prescriptions in 66 primary healthcare institutions in Beijing City, China, 2015-2018
by: Yumiti Taxifulati, et al.
Published: (2021)

Outpatient Antibiotic Prescribing Patterns in Children among Primary Healthcare Institutions in China: A Nationwide Retrospective Study, 2017-2019
by: Haishaerjiang Wushouer, et al.
Published: (2024)

Impact of national drug price negotiation policy on the accessibility and utilization of PCSK9 inhibitors in China: an interrupted time series analysis
by: Lingli Zhang, et al.
Published: (2024)

The impacts of the National Medication Price-Negotiated Policy on the financial burden of cancer patients in Shandong province, China: an interrupted time series analysis
by: Yi Ding, et al.
Published: (2022)

Psychotropic medication utilisation in adult cancer patients in China: A cross-sectional study based on national health insurance database
by: Lin Bai, et al.
Published: (2020)

Effects of the Full Coverage Policy of Essential Medicines on Inequality in Medication Adherence: A Longitudinal Study in Taizhou, China
by: Zhigang Guo, et al.
Published: (2022)

The impacts of implementation of National Essential Medicines Policies on primary healthcare institutions: a cross-sectional study in China
by: Zhigang Guo, et al.
Published: (2017)

The influence of the national drug price negotiation policy reform on the medical expenses of patients in Xuzhou City: an interrupted time series analysis
by: Zhaohui Qin, et al.
Published: (2024)

Measuring Temporal Trends and Patterns of Inpatient Antibiotic Use in Northwest China's Hospitals: Data from the Center for Antibacterial Surveillance, 2012-2022
by: Aizezijiang Aierken, et al.
Published: (2024)

Effect of the full coverage policy of essential medicines on medication adherence: A quasi-experimental study in Taizhou, China
by: Zhigang Guo, et al.
Published: (2022)

Promoting Access to Innovative Anticancer Medicines: A Review of Drug Price and National Reimbursement Negotiation in China
by: Xia Mingge MPH, et al.
Published: (2023)

Trends and relationship between antimicrobial resistance and antibiotic use in Xinjiang Uyghur Autonomous Region, China: Based on a 3 year surveillance data, 2014-2016
by: Haishaerjiang Wushouer, et al.
Published: (2018)

The impact of global budget on expenditure, service volume, and quality of care among patients with pneumonia in a secondary hospital in China: a retrospective study
by: Xiaodong Guan, et al.
Published: (2020)

Trends in the utilization of psychotropic medications in China from 2018 to 2021
by: Xinyan Zhang, et al.
Published: (2022)

Impact of Three Safety Interventions Targeting Off-Label Use of Immediate-Release Fentanyl on Prescription Trends: Interrupted Time Series Analysis
by: Aníbal García-Sempere, et al.
Published: (2022)

Impact of capitation on physicians' behavior among patients with hypertension: an interrupted time series study in rural China
by: Jiani Zhang, et al.
Published: (2024)

Improvements in the health-related quality-of-life benefit of cancer drugs approved in China, 2005-2020: an observational studyResearch in context
by: Lan Zhang, et al.
Published: (2024)

Interruption time series analysis using autoregressive integrated moving average model: evaluating the impact of COVID-19 on the epidemic trend of gonorrhea in China
by: Yanyan Li, et al.
Published: (2023)

Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease
by: Pengxin Dong, et al.
Published: (2018)

Negotiating the Christian Past in China Memory and Missions in Contemporary Xiamen
by: Liu, Jifeng
Published: (2022)

Negotiating the Christian Past in China Memory and Missions in Contemporary Xiamen
by: Liu, Jifeng
Published: (2022)

County Hospital Responses to Funding Reforms in Zhejiang, China: An Interrupted Time-Series Analysis
by: Tao Zhang, et al.
Published: (2023)

Pneumococcal meningitis trends after pneumococcal conjugate vaccine introduction in Colombia: An interrupted time-series analysis
by: Diana C. Caceres, et al.
Published: (2018)

Time trends and regional variations in prices of anticancer medicines in China
by: Jinwei Zhang, et al.
Published: (2024)